SHE:301096 - Hangzhou Bio-Sincerity Pharma-Tech Co Ltd

Hangzhou Bio-Sincerity Pharma-
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2017	2018	2019	2020	2021	2022	2023	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	-	-	-
Net Margin	[friend]	[friend]	[friend]	[friend]	29.68% 7.1%	31.97% 7.7%	26.73% -16.4%
Gross Margin	[friend]	[friend]	[friend]	[friend]	67.26% 2.2%	67.37% 0.2%	65.53% -2.7%
Operating Margin	[friend]	[friend]	[friend]	[friend]	33.43% 5.2%	26.48% -20.8%	29.28% 10.6%
Total Revenue	[friend]	[friend]	[friend]	[friend]	374.31M 80.6%	607.41M 62.3%	1.02B 67.5%
Total Assets	[friend]	[friend]	[friend]	[friend]	2.92B 344.0%	2.93B 0.2%	3.67B 25.2%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	607.1M 90.2%	447.45M -26.3%	984.97M 120.1%
Total Equity	[friend]	[friend]	[friend]	[friend]	2.32B 582.6%	2.48B 7.1%	2.68B 8.1%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	145.42M 167.5%	259.41M 78.4%	90.45M -65.1%
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	132.6M -29.8%	2.01B 1415.0%	1.21B -39.7%
End Cash Position	[friend]	[friend]	[friend]	[friend]	2.01B 1415.0%	1.21B -39.7%	778.45M -35.7%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	-103.02M -	-332.16M -	-598.15M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	110.97M 94.0%	194.04M 74.9%	272.01M 40.2%
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	1.37 93.0%	1.79 30.7%	2.51 40.2%
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	8.36% -55.0%	8.09% -3.2%	10.53% 30.1%
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	6.2% -44.0%	6.63% 7.0%	8.24% 24.3%